Jeffrey E Lee

17PUBLICATIONS
237CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyOther chemical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 26, 2026
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor.

Jin Guo, Kever A Lewis, Laura Prakash

|Jan 15, 2026
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma.

Adriana C Gamboa, Kever A Lewis, Laura R Prakash

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Jul 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma.

Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff

|Nov 07, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

Kathleen Conway, Sharon N Edmiston, Amanda Vondras

|Feb 26, 2024
Incomplete Carney Triad.

Steven G Waguespack, Neeta Somaiah, Jeffrey E Lee

Pageof 3

Frequent Collaborators

8 joint publications

Michael A Davies

7 joint publications

Jennifer L McQuade

7 joint publications

Hussein A Tawbi

7 joint publications

Sapna Patel